ITBMED
ITBMed is a biopharmaceutical company developing specific immunomodulatory biologics for organ transplantation, stem cell transplantation, and gene therapy. The lead candidate drug Siplizumab is a monoclonal antibody in late-stage clinical development, which has shown significant potential in transforming the life for organ transplant patients, by allowing the complete discontinuation of all immunosuppression treatment and restoration of a normal life.
ITBMED
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.itb-med.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Sitelinks Search Box
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Pablo Legoretta
Pablo Legoretta investment in Venture Round - ITBMed
Official Site Inspections
http://www.itb-med.com
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ITBMed"
About us - ITB-MED
ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly committed to advancing and exploring the potential of TCD601, with a …See details»
ITBMed - Crunchbase Company Profile & Funding
Contact Email [email protected] ITBMed is a biopharmaceutical company developing specific immunomodulatory biologics for organ transplantation, …See details»
ITB-MED - LinkedIn
ITB-MED | 1,671 followers on LinkedIn. ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly ...See details»
ITBMed Company Profile - Office Locations, Competitors, Revenue …
ITBMed $67 m in total funding,. See insights on ITBMed including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Team - ITB-MED
Our team has a long experience from pharmaceutical research and development, business development, entrepreneurship, transplantation surgery and immunology.See details»
ITB-Med Company Profile 2025: Valuation, Funding
When was ITB-Med founded? ITB-Med was founded in 2016. Where is ITB-Med headquartered? ITB-Med is headquartered in Stockholm, Sweden. What is the size of ITB-Med? ITB-Med has 48 total employees. What industry is ITB-Med …See details»
ITB-MED LLC Company Profile | New York, NY - Dun & Bradstreet
Itb-med llc. d&b business directory home / business directory / professional, scientific, and technical services / accounting, tax preparation, bookkeeping, and payroll services / united …See details»
ITB-MED AB Company Profile | Stockholm, Sweden | Competitors ...
Find company research, competitor information, contact details & financial data for ITB-MED AB of Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
Organization | ITB-Med LLC
Organization Overview. First Clinical Trial. 2020 NCT04311632. First Marketed Drug. None First NDA Approval. None Last Known Activity ... ITB-MED | ITB-Med LLC Active Ingredients. …See details»
ITBMed - Products, Competitors, Financials, Employees, …
Apr 6, 2018 ITBMed Completes up to $67M Equity Investment. Apr 6, 2018. ITBMed , a Stockholm, Sweden-based biopharmaceutical company focusing on the development of …See details»
ITBMed - VentureRadar
"ITBMed is a biopharmaceutical company developing specific immunomodulatory biologics for organ transplantation, stem cell transplantation, and gene therapy.See details»
Where passion meets purpose - ITB-MED
ITB-MED, founded in 2016, has grown to over 40 employees across offices in Stockholm and New York. Clinical trials are being conducted globally, with a particular focus on the United …See details»
Contact - ITB-MED
Please be cautious of fraudulent individuals and entities falsely claiming that ITB-MED has open employment positions. ITB-MED does not recruit or offer job positions through text messages, …See details»
ITB Med - Overview, News & Similar companies | ZoomInfo.com
ITB Med contact info: Phone number: (917) 455-4404 Website: www.itb-med.com What does ITB Med do? ITB Med AB is a company that operates in the Chemicals & Related Products …See details»
Current job openings - ITB-MED
ITB-MED, founded in 2016, has grown to over 40 employees across offices in Stockholm and New York. Clinical trials are being conducted globally, with a particular focus on the United …See details»
Malin Robin - ITB-MED
Malin Robin, BSc, PhL joined ITB-MED in November 2023 and brings nearly 30 years of pharmaceutical industry experience in all phases of drug development including launch to the …See details»
ITBMed (company) - Nordic 9
ITBMed (company). ITBMed is a biopharmaceutical company developing specific immunomodulatory biologics for organ transplantation, stem cell transplantation, and gene …See details»
Pipeline - ITB-MED
ITB-MED’s portfolio has projects in several focus areas and in various phases from discovery through clinical development. Our project portfolio as of May 28, 2024. Transplantation. …See details»
Michael J. Price - ITB-MED
Michael Price has spent 40 years in investment banking (at Evercore, Lazard and Morgan Stanley) and has advised senior management and board of directors on strategic matters …See details»